Physician profile
Jessica Arnold
NPI 1538518949
$1,161.46
in general payments reported to CMS, 2019-2025
12 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $76.85 · 2023: $304 · 2024: $252 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.64 |
| Education | $149.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.25 | 2021-2025 | |
| Janssen Biotech, INC. | $190.78 | 2023-2025 | Tremfya |
| Incyte Corporation | $104.14 | 2021 | |
| Revance Therapeutics, INC. | $93.45 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $93.27 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $65.66 | 2022-2024 | |
| Boston Scientific Corporation | $61.28 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.26 | 2021 | |
| Genzyme Corporation | $27.93 | 2025 | |
| Leo Pharma INC. | $25.68 | 2024 | Adbry |
| Pfizer INC. | $21.18 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $15.58 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.